Immediate Impact
3 by Nobel laureates 6 from Science/Nature 50 standout
Citing Papers
mRNA-based therapeutics: looking beyond COVID-19 vaccines
2024 StandoutNobel
Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial
2023 Standout
Works of Mark G. Kortepeter being referenced
Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit1
2008
Experience in the Medical Management of Potential Laboratory Exposures to Agents of Bioterrorism on the Basis of Risk Assessment at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID)
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark G. Kortepeter | 598 | 240 | 180 | 37 | 842 | |
| Beate Becker‐Ziaja | 770 | 143 | 86 | 31 | 853 | |
| Stephan Ölschläger | 742 | 166 | 84 | 22 | 886 | |
| Markus H. Kainulainen | 636 | 140 | 80 | 24 | 761 | |
| John D. Frame | 823 | 362 | 100 | 31 | 984 | |
| Augustine Goba | 886 | 271 | 103 | 24 | 959 | |
| Shelley Campbell | 749 | 166 | 49 | 17 | 897 | |
| Lin Eastaugh | 511 | 142 | 86 | 27 | 712 | |
| N’Faly Magassouba | 551 | 137 | 85 | 35 | 670 | |
| Danielle V. Clark | 298 | 94 | 138 | 40 | 685 | |
| Eva Mittler | 740 | 79 | 105 | 25 | 961 |
All Works
Login with ORCID to disown or claim papers
Loading papers...